Skip to main content

Table 3 Number and proportions of patients who used two or more antihypertensive drugs concurrently and adjusted odds ratios for change

From: Change in antihypertensive drug prescribing after guideline implementation: a controlled before and after study

 

Intervention

Controls

Intergroup comparison

 

2001

2003

Adjusted* OR (95% CI)

p-value

2001

2003

Adjusted* OR (95% CI)

p-value

Adjusted* OR (95% CI)

p-value

 

n (%)

  

n (%)

    

Hypertension

         
 

828 (36.8)

1164 (39.2)

1.12 (0.99, 1.25)

0.06

2119 (38.5)

2774 (41.3)

1.13 (1.05, 1.21)

0.002

0.99 (0.86, 1.13)

0.86

CHD

         
 

110 (34.4)

164 (37.3)

1.19 (0.87, 1.62)

0.23

292 (30.7)

389 (33.9)

1.10 (0.91, 1.33)

0.33

1.07 (0.75, 1.54)

0.70

Diabetes

         
 

144 (47.7)

250 (54.8)

1.33 (0.99, 1.79)

0.06

303 (49.5)

428 (51.7)

1.10 (0.89, 1.36)

0.38

1.22 (0.85, 1.75)

0.28

  1. Prescription data was drawn from the national Prescription Register during a three-month period in 2001 and 2003.
  2. Abbreviations: CHD, coronary heart disease; OR, Odds ratio; CI, confidence interval.
  3. *Within-group analysis: Logistic regression, random effects model (physician as a random effect). Adjusted for patient's age and patient's sex. Reference group: patients with one antihypertensive drug.
  4. **Intergroup analysis: Logistic regression, random effects model (physician as a random effect). A product term between time (after versus before) and group (intervention versus control) was added in the model. Adjusted for patient's age and patient's sex. Reference group: patients with one antihypertensive drug.
Back to article page

BMC Primary Care

ISSN: 2731-4553

Contact us